Dec 6, 2022 RESTEM Launches NK Cell Therapy Program with Publication of Results from Clinical Study of NK Cell Therapy Targeting Senescence and Age-Associated Disorders
https://www.prweb.com/releases/2022/11/prweb19029601.htm
Sep 6, 2022 RESTEM and JAR of Hope Foundation Announce Strategic Partnership and Clinical Trial Launch of Next-Generation Cell Therapy for Patients with Duchenne Muscular Dystrophy
https://www.prweb.com/releases/2022/9/prweb18866576.htm
Aug 2, 2022 UF Center for Regenerative Medicine recruiting for trial on potential therapy for autoimmune disorders
May 14, 2020 FDA approves COVID-19 trial after successful emergency use of umbilical stem cells from RESTEM